These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 4111418
1. [Biphasic therapy using Sequenz-Ovosiston for hormonal contraception]. Ebeling K, Kühndel K, Rothe K, Canzler E. Z Arztl Fortbild (Jena); 1971 Dec 15; 65(24):1275-8. PubMed ID: 4111418 [No Abstract] [Full Text] [Related]
3. [Clinical evaluation of the hormonal effect of ovosiston in various dosages]. Kühndel K, Ebeling K, Rothe K. Z Arztl Fortbild (Jena); 1971 Jan 15; 65(2):79-84. PubMed ID: 4104626 [No Abstract] [Full Text] [Related]
4. [Studies on the hormonal activity and progestagenic properties of Ovosiston preparation]. Krzywdziński K, Jedrzejewski M, Teter J. Ginekol Pol; 1969 Jan 15; 40(1):41-52. PubMed ID: 4181038 [No Abstract] [Full Text] [Related]
6. [Experiences with different doses of Ovosiston preparations within the scope of marital and sexual counseling. Individual therapy with oral contraceptives]. Ebeling K, Kühndel K, Rothe K. Dtsch Gesundheitsw; 1971 Jan 01; 26(1):31-4. PubMed ID: 4106517 [No Abstract] [Full Text] [Related]
8. [Clinical experience with the preparation Ovosiston with special reference to the cervix factor and vaginal cytology]. Müller R, Kempf HJ, Eckert L. Zentralbl Gynakol; 1968 Nov 16; 90(46):1545-55. PubMed ID: 4179333 [No Abstract] [Full Text] [Related]
9. [Amenorrhea-galactorrhea following the use of ovosiston]. Kosowski I, Stojanow G, Iliewa W. Zentralbl Gynakol; 1973 Jun 22; 95(25):851-4. PubMed ID: 4126137 [No Abstract] [Full Text] [Related]
10. [Experiences with Ovosiston in a new dosage form]. Zwahr C. Dtsch Gesundheitsw; 1970 Apr 08; 25(14):635-9. PubMed ID: 4098545 [No Abstract] [Full Text] [Related]
12. [Colposcopic, cytologic and histologic findings on the portio in contraceptive therapy using Ovosiston]. Kaiser P. Zentralbl Gynakol; 1970 Mar 28; 92(13):401-4. PubMed ID: 4104841 [No Abstract] [Full Text] [Related]
15. [Femigen forte and mite preparations in contraception and gynecologival disorders]. Sternadel Z, Pietrusiewicz W, Wasilewska B. Ginekol Pol; 1970 Nov 28; 41(11):1227-36. PubMed ID: 4098877 [Abstract] [Full Text] [Related]
16. The use of continuous progestogen contraception in the treatment of migraine. Somerville BW, Carey HM. Med J Aust; 1970 May 23; 1(21):1043-5. PubMed ID: 4193905 [No Abstract] [Full Text] [Related]
17. ["1st experiences with Ovosiston in a new dosage--a comparative study of oral contraception with 'old' and 'new' Ovosiston". "Experiences with Ovosiston in contraception. II. " Reply to the viewpoint of D. Kühne]. Zwahr C. Dtsch Gesundheitsw; 1970 Nov 19; 25(47):2247-50. PubMed ID: 4099776 [No Abstract] [Full Text] [Related]
18. [Sequenz-Ovosiston as a contraceptive agent]. Zwahr C. Zentralbl Gynakol; 1972 Dec 09; 94(49):1722-5. PubMed ID: 4119508 [No Abstract] [Full Text] [Related]
19. [Hormonal therapy of acne vulgaris. Ovulation inhibitors in premenstrual acne]. Schirren C, Immel L. Munch Med Wochenschr; 1969 Aug 29; 111(35):1742-7. PubMed ID: 4185512 [No Abstract] [Full Text] [Related]
20. [Treatment of erythema nodosum with an estrogen-gestagen hormonal preparation]. Spirov G, Vetsova N. Vestn Dermatol Venerol; 1975 Feb 29; (2):57-8. PubMed ID: 50675 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]